ZA200904330B - Process for preparing (1R, 2S,5S)-N-[(1S)-3-amino-1-(cyclobutylmethyl)-2-3-dioxopropyl]-3-3[(2S)-2[[[1,1-dimethylethyl)amino]-carbonyl]amino]-3,3-dimethyl-1-oxobutyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide - Google Patents

Process for preparing (1R, 2S,5S)-N-[(1S)-3-amino-1-(cyclobutylmethyl)-2-3-dioxopropyl]-3-3[(2S)-2[[[1,1-dimethylethyl)amino]-carbonyl]amino]-3,3-dimethyl-1-oxobutyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide

Info

Publication number
ZA200904330B
ZA200904330B ZA200904330A ZA200904330A ZA200904330B ZA 200904330 B ZA200904330 B ZA 200904330B ZA 200904330 A ZA200904330 A ZA 200904330A ZA 200904330 A ZA200904330 A ZA 200904330A ZA 200904330 B ZA200904330 B ZA 200904330B
Authority
ZA
South Africa
Prior art keywords
amino
dimethyl
dioxopropyl
oxobutyl
cyclobutylmethyl
Prior art date
Application number
ZA200904330A
Other languages
English (en)
Inventor
George S K Wong
Hong-Chang Lee
Jennifer A Vance
Weidong Tong
Tetsuo Iwama
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of ZA200904330B publication Critical patent/ZA200904330B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ZA200904330A 2006-12-20 2009-06-19 Process for preparing (1R, 2S,5S)-N-[(1S)-3-amino-1-(cyclobutylmethyl)-2-3-dioxopropyl]-3-3[(2S)-2[[[1,1-dimethylethyl)amino]-carbonyl]amino]-3,3-dimethyl-1-oxobutyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide ZA200904330B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US87644706P 2006-12-20 2006-12-20

Publications (1)

Publication Number Publication Date
ZA200904330B true ZA200904330B (en) 2010-04-28

Family

ID=39232899

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200904330A ZA200904330B (en) 2006-12-20 2009-06-19 Process for preparing (1R, 2S,5S)-N-[(1S)-3-amino-1-(cyclobutylmethyl)-2-3-dioxopropyl]-3-3[(2S)-2[[[1,1-dimethylethyl)amino]-carbonyl]amino]-3,3-dimethyl-1-oxobutyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide

Country Status (14)

Country Link
US (1) US8163937B2 (xx)
EP (1) EP2121605B1 (xx)
JP (1) JP4955779B2 (xx)
CN (1) CN101611000B (xx)
AR (1) AR064465A1 (xx)
CA (1) CA2672620A1 (xx)
ES (1) ES2439246T3 (xx)
HK (1) HK1133261A1 (xx)
HR (1) HRP20131156T1 (xx)
MX (1) MX2009006884A (xx)
PL (1) PL2121605T3 (xx)
PT (1) PT2121605E (xx)
WO (1) WO2008079216A1 (xx)
ZA (1) ZA200904330B (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200924774A (en) * 2007-10-26 2009-06-16 Astrazeneca Ab Fused pyrrolidine 1,2,4-triazole derivatives as modulators of mGluR5
EP2704570A4 (en) * 2011-05-04 2015-02-18 Merck Sharp & Dohme ACTIVE SUBSTANCES, PHARMACEUTICAL COMPOSITIONS AND METHOD FOR THE PRODUCTION THEREOF
CN103508918B (zh) * 2012-06-18 2015-09-09 上海医药工业研究院 带有环丁基的α-羟基β-氨基酯类化合物及其制备方法
WO2014061034A1 (en) * 2012-10-18 2014-04-24 Msn Laboratories Limited Process for preparation of boceprevir and intermediates thereof
WO2014083575A2 (en) 2012-11-29 2014-06-05 Mylan Laboratories Ltd Improved process for the preparation of boceprevir intermediate
CN103936652B (zh) * 2013-01-18 2016-07-06 上海医药工业研究院 抗丙肝药物Boceprevir的中间体IV及其制备方法和应用
CN103936651B (zh) * 2013-01-18 2016-06-22 上海医药工业研究院 抗丙肝药物Boceprevir的中间体Ⅲ及其制备方法和应用
CN103936818B (zh) * 2013-01-18 2017-09-29 上海医药工业研究院 抗丙肝药物Boceprevir的中间体Ⅰ及其制备方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL206255B1 (pl) * 2000-07-21 2010-07-30 Dendreon Corporationdendreon Corporation Inhibitor proteazy wirusa zapalenia wątroby C, zawierająca go kompozycja farmaceutyczna i zastosowanie inhibitora do wytwarzania leku do leczenia chorób związanych z HCV oraz zastosowanie do wytwarzania kompozycji do stosowania w kombinowanej terapii
AR044694A1 (es) * 2003-06-17 2005-09-21 Schering Corp Proceso y compuestos intermedios para la preparacion de (1r, 2s,5s) - 3 azabiciclo [3,1,0] hexano-2- carboxamida, n- [3- amino-1- (ciclobutilmetil) - 2, 3 - dioxopropil] -3- [ (2s) - 2 - [[ [ 1,1- dimetiletil] amino] carbonilamino] -3,3-dimetil -1- oxobutil]-6,6 dimetilo
AR049635A1 (es) * 2004-05-06 2006-08-23 Schering Corp (1r,2s,5s)-n-((1s)-3-amino-1-(ciclobutilmetil)-2,3-dioxopropil)-3-((2s)-2-((((1,1-dimetiletil)amino)carbonil)amino)-3,3-dimetil-1-oxobutil)-6,6-dimetil-3-azabiciclo(3.1.0)hexan-2-carboxamida como inhibidor de la ns3/ns4a serina proteasa del virus de la hepatitis c

Also Published As

Publication number Publication date
WO2008079216A1 (en) 2008-07-03
AR064465A1 (es) 2009-04-01
PT2121605E (pt) 2014-02-11
EP2121605A1 (en) 2009-11-25
CN101611000B (zh) 2013-08-21
JP2010513499A (ja) 2010-04-30
PL2121605T3 (pl) 2014-05-30
JP4955779B2 (ja) 2012-06-20
ES2439246T3 (es) 2014-01-22
US20100145013A1 (en) 2010-06-10
EP2121605B1 (en) 2013-11-20
CA2672620A1 (en) 2008-07-03
HK1133261A1 (en) 2010-03-19
HRP20131156T1 (hr) 2014-01-03
CN101611000A (zh) 2009-12-23
US8163937B2 (en) 2012-04-24
MX2009006884A (es) 2009-07-03

Similar Documents

Publication Publication Date Title
ZA200904330B (en) Process for preparing (1R, 2S,5S)-N-[(1S)-3-amino-1-(cyclobutylmethyl)-2-3-dioxopropyl]-3-3[(2S)-2[[[1,1-dimethylethyl)amino]-carbonyl]amino]-3,3-dimethyl-1-oxobutyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide
ZA200509100B (en) Process and intermediates for the preparation of (1r,2s,5s)-3-azabicyclo[3,1,0,]hexane-2-carboxamide,n-[3-amino-1-(cyclobutylmethyl)-2,3-doixopropyl]-3-[(2s)-2-[[[1,1-dimethylethyyl]amino]carbonylamino]-3,3-dimethyl-1-oxobuthyl]-6,6-dimethyl
WO2008082508A3 (en) Process for the preparation of 6,6-dimethyl-3-azabicyclo- [3.1.0]- hexane compounds utilizing bisulfite intermediate
EP2455462A3 (en) Lipase variants for pharmaceutical use
IL182581A (en) Processes for the preparation of a polypeptide containing l-tyrosine, l-alanine, l-glutamate and l-lysine
WO2007019255A3 (en) Salts of vildagliptin
EP2409988A3 (en) Peptide fragments for inducing synthesis of extracellular matrix proteins
WO2006132670A3 (en) Auristatins having an aminobenzoic acid unit at the n terminus
WO2005074970A3 (en) Neuroprotective dietary supplement
EP3249405A3 (en) Stabilizing composition for immobilized biomolecules
WO2007139933A3 (en) Processes for the preparation of r-(+)-3-(carbamoyl methyl)-5-methylhexanoic acid and salts thereof
WO2008148755A3 (en) Novel 5-substituted hydantoins
WO2007118660A3 (en) Her-2/neu multi-peptide vaccine
EP2112907A4 (en) PEARL FOR SEWING, VACUUM CAP FOR SUCKING AN INNER ORGAN AND DEVICE FOR SEWING AN INNER ORGAN
HK1210011A1 (zh) -{ }- -{ -二甲氧二環 辛- -三烯- -基 甲基}- -二甲氧基- -四氫- -苯並氮雜䓬- -基 -甲基- -氧代- -丙胺和培哚普利的組合
HUP0500862A2 (en) Carrier materials for mosquito-larvae killing pesticides, mosquito-larvae killing products and process for producing thereof
WO2008076316A3 (en) Bisulfite purification of an alpha-keto amide
WO2010079013A3 (en) Umami active fraction, method to prepare the same, method of enhancing umami taste and method of preparing a food product
ZA200804110B (en) An oxidation process for the preparation of N-[3-amino-1-(cyclobutylmethyl)-2,3- dioxopropyl]-3-{N-[(tert-buty-lamino)carbonyl]-3-methyl-L-valyl}-6,6-dimethyl-3-azabicy-clo[3.1.0]hexane-2-carboxamide and related compounds
HK1147751A1 (en) Carbamoylglycine derivatives
WO2009017775A3 (en) Process for the preparation of a polypeptide
WO2009122433A3 (en) A process for preparation of ramipril
WO2007044574A3 (en) Pharmaceutical compositions, methods of preparation thereof, and methods of treatment
WO2011112100A8 (en) Peptide material, feed composition and preparations and uses thereof
Lawton et al. Medicinial chemistry. Preface